Literature DB >> 1437153

Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.

A P Albino1, G Sozzi, D M Nanus, S C Jhanwar, A N Houghton.   

Abstract

Human melanoma provides a model to study malignant transformation and tumor progression. Expression of ras oncogenes in cultured normal human diploid melanocytes has induced a subset of phenotypic traits that are characteristic of malignant melanoma cells, including altered morphology, anchorage independence, induction of class II MHC antigens, up-regulation of the ganglioside GD3, and chromosomal abnormalities. However, other characteristics of melanoma, such as loss of expression of adenosine deaminase-binding protein and tumorigenicity, were not observed. We report here that melanocytes infected with a retrovirus containing the viral Ha-ras oncogene underwent complete transformation, acquiring all phenotypic characteristics of malignant melanomas observed in vivo. Transformation occurred in a sequential manner and was associated with spontaneous chromosomal instability. Cytogenetic analysis of transformed melanocytes indicated that the earliest structural chromosomal abnormalities were isochromosomes 6p and 9q followed by complete loss of chromosome 1p, all common karyotypic abnormalities described in human melanomas. The findings suggest that these chromosome regions which are deleted or relatively deficient may contain genes that are critical for the initiation and progression of the melanoma phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437153

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells.

Authors:  M Kortylewski; P C Heinrich; M E Kauffmann; M Böhm; A MacKiewicz; I Behrmann
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.

Authors:  Eleazar Vega-Saenz de Miera; Erica B Friedman; Holly S Greenwald; Mary A Perle; Iman Osman
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

Review 3.  Activated ras. Yet another player in melanoma?

Authors:  M Herlyn; K Satyamoorthy
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

Authors:  B C Bastian; P E LeBoit; D Pinkel
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.

Authors:  L Chin; J Pomerantz; D Polsky; M Jacobson; C Cohen; C Cordon-Cardo; J W Horner; R A DePinho
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

6.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

7.  Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells.

Authors:  Eric Yvon; Michele Del Vecchio; Barbara Savoldo; Valentina Hoyos; Aurélie Dutour; Andrea Anichini; Gianpietro Dotti; Malcolm K Brenner
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

8.  Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.

Authors:  M Jafari; T Papp; S Kirchner; U Diener; D Henschler; G Burg; D Schiffmann
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Authors:  U V Wesley; A P Albino; S Tiwari; A N Houghton
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

10.  A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.

Authors:  M E Morrison; S Vijayasaradhi; D Engelstein; A P Albino; A N Houghton
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.